Cargando…
Sex and gender perspectives in colorectal cancer
Historically women were frequently excluded from clinical trials and drug usage to protect unborn babies from potential harm. As a consequence, the impact of sex and gender on both tumour biology and clinical outcomes has been largely underestimated. Although interrelated and often used interchangea...
Autores principales: | Baraibar, I., Ros, J., Saoudi, N., Salvà, F., García, A., Castells, M.R., Tabernero, J., Élez, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163160/ https://www.ncbi.nlm.nih.gov/pubmed/37018873 http://dx.doi.org/10.1016/j.esmoop.2023.101204 |
Ejemplares similares
-
Encorafenib plus cetuximab for the treatment of
BRAF-V600E-mutated metastatic colorectal
cancer
por: Ros, Javier, et al.
Publicado: (2022) -
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021) -
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023) -
The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey
por: Rodriguez Castells, Marta, et al.
Publicado: (2023) -
Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
por: Saoudi González, Nadia, et al.
Publicado: (2023)